Sign in

CIK 0001509261

  • Non-accelerated filer
  • Smaller reporting company

Rezolute, Inc.

Sign in to watch
Ticker
RZLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
NV
Entity type
Operating
EIN
273440894
Phone
+1 650-206-4507
Business address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
Former names
AntriaBio, Inc., FITS MY STYLE INC
  1. 4 Open-market buy Chief Medical Officer bought 7,500 shares at an average $2.69 ($20,138)
  2. 4 Open-market buy CFO bought 3,000 shares at an average $3.22 ($9,668)
  3. 4 Open-market buy Chief Medical Officer bought 500 shares at $2.55 ($1,275)
  4. 4 Open-market buy Director bought 3,927,126 shares at an average $4.33 ($17,000,003)
  5. 4 Open-market buy CFO bought 20,000 shares at $1.69 ($33,830)
  6. 4 Open-market buy Chief Medical Officer bought 10,000 shares at $1.88 ($18,800)
  7. 4/A Open-market buy Chief Medical Officer bought 500 shares at $1.85 ($925)
  8. 4 Open-market buy Director bought 115,450 shares at an average $3.20 ($369,858)
  9. 4 Open-market buy Chief Medical Officer bought 500 shares at $1.85 ($925)
  10. 4 Open-market buy CFO bought 50,000 shares at $1.93 ($96,345)
  11. 4 Open-market buy CEO bought 5,000 shares at $1.68 ($8,400)
  12. 4 Open-market buy Chief Medical Officer bought 8,000 shares at an average $1.69 ($13,540)
  13. 4 Open-market buy Chief Medical Officer bought 7,000 shares at $1.31 ($9,142)
  14. 4 Open-market buy CFO bought 50,900 shares at an average $1.31 ($66,741)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 11 · 208 filings